140 related articles for article (PubMed ID: 3594830)
1. Improved interassay correlation of digoxin results in patients with and without renal failure by elimination of digoxin-like immunoreactive factors.
Skogen WF; Rea MR; Valdes R
Clin Chem; 1987 Jun; 33(6):837-9. PubMed ID: 3594830
[TBL] [Abstract][Full Text] [Related]
2. A physician's office-based digoxin assay (Seralyzer) evaluated for interference by endogenous digoxin-like immunoreactive factors.
Matheke ML; Valdes R
Ann Clin Lab Sci; 1989; 19(3):168-74. PubMed ID: 2658726
[TBL] [Abstract][Full Text] [Related]
3. Endogenous digoxin-like immunoreactive factors eliminated from serum samples by hydrophobic silica-gel extraction and enzyme immunoassay.
Skogen WF; Rea MR; Valdes R
Clin Chem; 1987 Mar; 33(3):401-4. PubMed ID: 3545537
[TBL] [Abstract][Full Text] [Related]
4. Effect of antibody specificity on results of selected digoxin immunoassays among various clinical groups.
Datta P; Xu L; Malik S; Landicho D; Ferreri L; Halverson K; Roby PV; Zebelman AM; Kenny MA
Clin Chem; 1996 Mar; 42(3):373-9. PubMed ID: 8598098
[TBL] [Abstract][Full Text] [Related]
5. Endogenous digoxin-like immunoreactive factors (DLIF) as measured by the CEDIA digoxin assay and a fluorescence polarization immunoassay.
Schlebusch H; Jarausch J; Domke I
Wien Klin Wochenschr Suppl; 1992; 191():59-66. PubMed ID: 1509757
[TBL] [Abstract][Full Text] [Related]
6. Interference of digoxin-like immunoreactive substances with three digoxin immunoassays in patients with various degrees of renal function.
Pleasants RA; Gadsden RH; McCormack JP; Piveral K; Sawyer WT
Clin Pharm; 1986 Oct; 5(10):810-6. PubMed ID: 3780148
[TBL] [Abstract][Full Text] [Related]
7. Interference of endogenous digoxin-like immunoreactive factors in serum digoxin measurement is minimized in a new turbidimetric digoxin immunoassay on ADVIA 1650 analyzer.
Datta P; Dasgupta A
Ther Drug Monit; 2004 Feb; 26(1):85-9. PubMed ID: 14749555
[TBL] [Abstract][Full Text] [Related]
8. Digoxin-like immunoreactivity in serum from neonates and infants reduced by centrifugal ultrafiltration and fluorescence polarization immunoassay.
Ray JE; Crisan D; Howrie DL
Clin Chem; 1991 Jan; 37(1):94-8. PubMed ID: 1988216
[TBL] [Abstract][Full Text] [Related]
9. Methods for eliminating interferences in digoxin immunoassays caused by digoxin-like factors.
Graves SW; Sharma K; Chandler AB
Clin Chem; 1986 Aug; 32(8):1506-9. PubMed ID: 3755385
[TBL] [Abstract][Full Text] [Related]
10. Marked digoxin-like immunoreactive factor interference with an enzyme immunoassay.
Karboski JA; Godley PJ; Frohna PA; Horton MW; Reitmeyer WJ
Drug Intell Clin Pharm; 1988 Sep; 22(9):703-5. PubMed ID: 3063480
[TBL] [Abstract][Full Text] [Related]
11. Treatment of human serum with sulfosalicylic acid structurally alters digoxin and endogenous digoxin-like immunoreactive factor.
Qazzaz HM; Goudy S; Miller JJ; Valdes R
Ther Drug Monit; 1995 Feb; 17(1):53-9. PubMed ID: 7725377
[TBL] [Abstract][Full Text] [Related]
12. Dialyzability and binding of digoxin-like immunoreactive factors (DLIF) with serum macromolecules in uremic patients on hemodialysis.
Dasgupta A; Peng Y
Life Sci; 1991; 49(22):1603-9. PubMed ID: 1943464
[TBL] [Abstract][Full Text] [Related]
13. Digoxin-like immunoreactive substance in renal failure: a reappraisal.
Greenway DC; Nanji AA
Nephron; 1986; 44(2):108-10. PubMed ID: 3774074
[TBL] [Abstract][Full Text] [Related]
14. Endogenous digoxin-like immunoreactive factors: impact on digoxin measurements and potential physiological implications.
Valdes R
Clin Chem; 1985 Sep; 31(9):1525-32. PubMed ID: 3896570
[TBL] [Abstract][Full Text] [Related]
15. Comparison of four digoxin immunoassays with respect to interference from digoxin-like immunoreactive factors.
Datta P; Hinz V; Klee G
Clin Biochem; 1996 Dec; 29(6):541-7. PubMed ID: 8939401
[TBL] [Abstract][Full Text] [Related]
16. Improving the specificity of digoxin immunoassays.
Valdes R
Wien Klin Wochenschr Suppl; 1992; 191():55-9. PubMed ID: 1509756
[TBL] [Abstract][Full Text] [Related]
17. New enzyme-linked immunosorbent digoxin assay on the ADVIA IMS 800i system is virtually free from interference of endogenous digoxin-like immunoreactive factors.
Dasgupta A; Kang E; Datta P
Ther Drug Monit; 2005 Apr; 27(2):139-43. PubMed ID: 15795642
[TBL] [Abstract][Full Text] [Related]
18. Criteria for identifying endogenous compounds as digoxin-like immunoreactive factors in humans.
Lau BW; Valdes R
Clin Chim Acta; 1988 Jun; 175(1):67-77. PubMed ID: 2844442
[TBL] [Abstract][Full Text] [Related]
19. A new digoxin immunoassay substantially free of interference by digoxin immunoreactive factor.
Jiang F; Wilhite TR; Smith CH; Landt M
Ther Drug Monit; 1995 Apr; 17(2):184-8. PubMed ID: 7624908
[TBL] [Abstract][Full Text] [Related]
20. Digoxin-like immunoreactive substances in the plasma of intensive care unit patients: relationship to organ dysfunction.
Howarth DM; Sampson DC; Hawker FH; Young A
Anaesth Intensive Care; 1990 Feb; 18(1):45-52. PubMed ID: 2159733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
